Please login to the form below

Not currently logged in
Email:
Password:

EC approves Pegasys

Roche has revealed that the European Commission approved its hepatitis C medicine, Pegasys. The company says the drug could lead to patients being cured in four months
Roche has revealed that the European Commission (EC) approved its hepatitis C medicine, Pegasys. The company says the drug could lead to patients being cured in four months.

It has been developed as a 16-week treatment for the genotype 2 and 3 strains of hepatitis C in patients with low virus levels. The company hopes that the shorter treatment rates will reduce patients' exposure to drug therapies.

Previous to the approval of Pegasys, patients had to undergo 24 weeks of treatment, even if they had low virus levels and rapid response rates to the medicine.

William Burns, CEO of Roche pharmaceuticals division, explained that the company is committed to advancing the use of personalised medicine, which accounts for patients' reaction and medical history.

"This approval for 16 weeks of treatment in genotype 2 and 3 patients with a rapid response demonstrates the value of using diagnostic tools to determine an individual treatment regime and hopefully will encourage more eligible patients to come forward for treatment," he said.

26th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics